Funding brief: The InnoVet-AMR initiative addresses antibiotic resistance and is divided into two themes focused on reducing the use of antibiotics in the livestock (poultry and swine) and aquaculture (fish and shellfish) sectors in low and middle income countries. The main goal of both themes is to develop innovative veterinary solutions, focusing on product development, to reduce the therapeutic (prevention and control) and non-therapeutic (growth promotion) use of antibiotics, while still protecting animal health and welfare.
Research supported in this fund will be expected to understand and address the local contexts and realities which drive antibiotic-usage patterns on farms in developing countries, in order to ensure that innovations are relevant, feasible, practical and appropriate for the ultimate uptake and use by farmers, veterinarians and paraveterinarians in developing countries.
Research proposals must focus on veterinary solutions, where new or improved product oriented-solutions would significantly reduce the therapeutic and/or non-therapeutic use of antibiotics in low and middle income countries in poultry, swine, and/or aquaculture (fish and shellfish) production. These solutions must target the prevention and control of infectious diseases of importance in low and middle income countries and the reduction of the use of antibiotics as growth promoters.
These product-oriented solutions include:
● The development of vaccines, vaccine administration/delivery methods; or
● The development of alternatives to antibiotics, including but not limited to pro- and prebiotics, immunomodulators and bacteriophages.
They will only consider veterinary solutions that address:
● Infectious diseases of importance to low and middle income countries;
● The reduction of use and/or misuse of antibiotics;
● Antibiotic resistance (research projects can target any pathogen as long as a relevant link can be made to minimizing the development and spread of antibiotic resistance and/or use/misuse of antibiotics).
They will give highest priority to projects that:
● Present a compelling justification for the proposed innovative veterinary solution, are scientifically sound and clearly describe how this approach will curb antibiotic use and the development of antibiotic resistance in the livestock and aquaculture sectors in low and middle income countries
● Demonstrate clear plans for sustainability of the proposed solution
● Support innovations at the technology readiness level (TRL) 3 to 6, that is early-stage product development, excluding fundamental research
● Demonstrate strong capacity to generate timely results based on specific milestones and within the allocated budget
● Include and describe a future ‘Commercialization and Adoption plan’ for the veterinary solutions to be developed and ready for use in developing countries
● Include and describe effective partnerships with organizations in low and middle income countries
● Show an awareness of medicines regulation and/or the intent to engage with a Government Regulatory Body for veterinary medicines in low and middle income countries.
They will NOT consider funding proposals that:
● Do not consider antibiotic resistance
● Do not consider swine, poultry or aquaculture (fish or shellfish)
● Are focused on new antibiotic drug discovery
● Are focused on improving animal husbandry and farm management
● Are to develop diagnostic devices
● Are focused on the development of surveillance platforms
● Are to pilot test new biomarkers or combinations of biomarkers
● Are to develop alternatives solutions to antibiotics not relevant to low and middle income countries
● Are to carry out field trials only
● Are designed for fundamental research, corresponding to TRL 1 and 2
● Are related only to registration or commercialization issues.
The ultimate intended outcome of InnoVet-AMR: To reduce the threat of antibiotic resistance to human health by minimizing the misuse of antibiotics and the development and spread of antibiotics resistance in developing countries, through the development and uptake of innovative veterinary products.
Donor Name: International Development Research Centre (IDRC), Centre de recherché pour e deveppement International
Funding name: Call for proposals: Developing innovative veterinary solutions for the fight against antimicrobial resistance (InnoVet-AMR)
Deadline: September, 12th, 2018 at 11:00am Eastern Daylight Time (Ottawa); 3:00pm Greenwich Mean Time
Funding details link: Click to view
Funding limit: Projects must be between CA$1 to 3 million each for up to 33 months. Projects should plan for 1.5 months start-up, 30 months to conduct research, and 1.5 months to close.
Special Notes: Please contact with the donor directly for further clarification and understanding.
Project start date: Projects are expected to begin in either March or April of 2019.
Project duration: 33 months
Eligible organization: As below
● Eligible research teams should be working on veterinary solutions to reduce antimicrobial resistance (AMR) with a focus on poultry, swine, or aquaculture animals. At least one of the administering institutions should be based in a low or middle-income country.
● The proposed veterinary solution must focus on poultry, swine, or aquaculture animals.
● The research team must include at least one researcher from an institution based in a low or middle-income country as principle investigator or co-applicant.
● Applicants from academia, private, and public sector organizations with a strong research focus are eligible for this global call.
● Applicants from the UN system are not eligible to apply to this call as lead or co-applicant organizations, but they may participate as collaborating organizations.
● Applicants from the Consultative Group on International Agricultural Research Centres are not eligible as a lead organization, but are eligible as co-applicants or collaborating organizations.
● The lead applicant and co-applicants may negotiate and develop funding arrangements directly with third-party organizations for specific services. IDRC will not contract directly with third-party organizations. Applications that involve third-party organizations must clearly justify their involvement and explain their role(s). The total third-party participation in a project is set at a maximum of 30% of the budget. At most, a person can apply as the principle investigator for one project and be a co-applicant for one additional project.
Eligible Country: Central Asia, Far East Asia, Middle East, North and Central America, North of Sahara, Oceania, South America, South Asia, South of Sahara, West Indies
Submission mail: Not found
● World Organisation for Animal Health (OIE): Click to view
● Canadian Environmental Assessment Agency, 2012: Click to view
● World Health Organization (WHO): Click to view
● Organisation for Economic Co-operation and Development (OECD): Click to view
● European Commission: Click to view
How to apply: Interested applicant may apply through the website (Click to view).
Facebook page-Fund for Bangladesh